Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Warfarin treatment of a patient with coagulation factor IX propeptide mutation causing warfarin hypersensitivity.

Blood - 1 Oct 2002

Kristensen Søren Risom

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Aspirin
Share to Drug Hypersensitivity
Share to Factor IX

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Valve Prosthesis Implantation

Share to International Normalized Ratio

Share to Partial Thromboplastin Time

Share to Warfarin

Source

Identifiers

PMID: 12360981
DOI: 10.1182/blood-2002-06-1753

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Warfarin treatment of a patient with coagulation factor IX propeptide mutation causing warfarin hypersensitivity.PMID 12360981Read ↗

Variants in FIX propeptide associated with vitamin K antagonist hypersensitivity: functional analysis and additional data confirming the common founder mutations.Semantic proximity Read ↗

The Conundrum of "Warfarin Hypersensitivity": Prolonged Partial Thromboplastin Time From Factor IX Propeptide Mutation.Semantic proximity Read ↗

Factor IX propeptide mutation and life threatening bleeding.Semantic proximity Read ↗

Haemophilia B caused by mutation of a potential thrombin cleavage site in factor IX.Semantic proximity Read ↗

Genetic susceptibility to hemorrhagic complications during warfarin therapy.Semantic proximity Read ↗

Implication of novel CYP2C9*57 (p.Asn204His) variant in coumarin hypersensitivity.Semantic proximity Read ↗

Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy.Semantic proximity Read ↗

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient.Semantic proximity Read ↗

A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy.Semantic proximity Read ↗

Factor V Leiden mutation in a patient with warfarin-associated skin necrosis.Semantic proximity Read ↗

Activated protein C concentrate treatment for skin necrosis under warfarin treatment in severe genetic protein C deficiency combined with prothrombin mutation and factor V Leiden.Semantic proximity Read ↗

Effect of five therapeutic strategies on the coagulation defect induced by the thrombomodulin c.1611C>A mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.